Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.

[1]  J. Kaper,et al.  A plasmid-encoded regulatory region activates chromosomal eaeA expression in enteropathogenic Escherichia coli , 1995, Infection and immunity.

[2]  N. Fairweather,et al.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Hoffman,et al.  Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. , 1994, The Journal of infectious diseases.

[4]  E. Lin,et al.  Adaptation of Escherichia coli to redox environments by gene expression , 1993, Molecular microbiology.

[5]  L. Eidels,et al.  Structure-function analyses of diphtheria toxin by use of monoclonal antibodies , 1993, Infection and immunity.

[6]  Characterization of the diphtheria toxin receptor‐binding domain , 1993, Molecular microbiology.

[7]  I. Charles,et al.  Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus Vaccine , 1992, Bio/Technology.

[8]  D. Russell,et al.  Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor , 1992, Cell.

[9]  Katherine A. Kantardjieff,et al.  The crystal structure of diphtheria toxin , 1992, Nature.

[10]  M. Levine,et al.  Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers , 1992, Infection and immunity.

[11]  E. Paoletti,et al.  Potential use of non-replicating vectors as recombinant vaccines. , 1992, Vaccine.

[12]  I. Charles,et al.  Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. , 1992, Vaccine.

[13]  M. Levine,et al.  Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. , 1992, Vaccine.

[14]  G. Dougan,et al.  Construction of genetically defined double aro mutants of Salmonella typhi. , 1991, Vaccine.

[15]  I. Charles,et al.  High level heterologous expression in E. coli using the anaerobically-activated nirB promoter. , 1991, Nucleic acids research.

[16]  H. Gaudin,et al.  Localization of the diphtheria toxin receptor-binding domain to the carboxyl-terminal Mr approximately 6000 region of the toxin. , 1990, The Journal of biological chemistry.

[17]  J. Clements,et al.  Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins , 1990, Infection and immunity.

[18]  S. Stibitz,et al.  Cloning and expression of functional fragment C of tetanus toxin , 1990, Infection and immunity.

[19]  N. Fairweather,et al.  Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons. , 1989, Nucleic acids research.

[20]  D. Acheson,et al.  Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies , 1989, Infection and immunity.

[21]  D. Sack,et al.  Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. , 1988, The Journal of infectious diseases.

[22]  G. Keusch,et al.  Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity , 1988, Infection and immunity.

[23]  W. Bishai,et al.  High-level expression of a proteolytically sensitive diphtheria toxin fragment in Escherichia coli , 1987, Journal of bacteriology.

[24]  P. Jayaraman,et al.  Location and sequence of the promoter of the gene for the NADH-dependent nitrite reductase of Escherichia coli and its regulation by oxygen, the Fnr protein and nitrite. , 1987, Journal of molecular biology.

[25]  R. Wagner,et al.  Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule , 1984, Infection and immunity.

[26]  M. Inouye,et al.  Novel High-level Expression Cloning Vehicles: 104-fold Amplification of Escherichia coli Minor Protein , 1984, Bio/Technology.

[27]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[28]  G. Buck,et al.  Nucleotide sequence of the structural gene for diphtheria toxin carried by corynebacteriophage beta. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Kurosky,et al.  Antigenic Specificity of Neutralizing Antibody to Cholera Toxin , 1979, Infection and immunity.

[30]  M. Schwab,et al.  AN ANTIGENIC POLYPEPTIDE FRAGMENT ISOLATED FROM TETANUS TOXIN: CHEMICAL CHARACTERIZATION, BINDING TO GANGLIOSIDES AND RETROGRADE AXONAL TRANSPORT IN VARIOUS NEURON SYSTEMS , 1977, Journal of neurochemistry.

[31]  J. H. Quastel,et al.  Experiments on "Strict" Anaerobes: The Relationship of B. sporogenes to Oxygen. , 2022, Biochemical Journal.